Influence of Whole Body Vibration Compared to Conventional Physiotherapy in Patients With Gonarthrosis
NCT ID: NCT01037972
Last Updated: 2011-10-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
40 participants
OBSERVATIONAL
2010-03-31
2011-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The outcome will be measured by WOMAC and SF-12 scores relating to pain and quality of life. The second outcome criteria will be a motion analysis and balance testing before and after the training.
The follow-up is 26 weeks.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Whole body vibration
Whole body vibration
3 times weekly 30 minutes of exercises on a whole body vibration device to strengthen muscular strength and improve muscular balance in the lower extremity.
Conventional physiotherapy
Conventional physiotherapy
3 times weekly 30 minutes of conventional physiotherapy to strengthen muscular strength and balance in the lower extremity.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Conventional physiotherapy
3 times weekly 30 minutes of conventional physiotherapy to strengthen muscular strength and balance in the lower extremity.
Whole body vibration
3 times weekly 30 minutes of exercises on a whole body vibration device to strengthen muscular strength and improve muscular balance in the lower extremity.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* WOMAC 30-70 mm (VAS)
* Gonarthrosis (Kellgren/Lawrence) II-III
Exclusion Criteria
* Endoprosthesis in lower extremity
* BMI \>40 kg/m2
30 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Cologne
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. Gregor Stein
Dr. med
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kourosh Zarghooni, MD
Role: PRINCIPAL_INVESTIGATOR
University of Cologne
Gregor Stein, MD
Role: STUDY_DIRECTOR
University of Cologne
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital of Cologne
Cologne, , Germany
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Stein G, Knoell P, Faymonville C, Kaulhausen T, Siewe J, Otto C, Eysel P, Zarghooni K. Whole body vibration compared to conventional physiotherapy in patients with gonarthrosis: a protocol for a randomized, controlled study. BMC Musculoskelet Disord. 2010 Jun 21;11:128. doi: 10.1186/1471-2474-11-128.
Related Links
Access external resources that provide additional context or updates about the study.
University Hospital of Cologne
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2009-017617-29
Identifier Type: REGISTRY
Identifier Source: secondary_id
Galileo
Identifier Type: -
Identifier Source: org_study_id